🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mark Voloshin

Moscow Clinical Scientific Center

ORCID: 0000-0002-2302-3542

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)”.

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)

Oncogenesis(2021)10.1038/s41389-021-00317-y

N/A

0DataRank · unranked

37 citations

Igor Bychkov, Bulat Faezov, Alexander Y. Deneka, Alexander E. Kudinov, Émmanuelle Nicolas +18 more

Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)

Journal of Thoracic Disease(2021)10.21037/jtd-20-2787

N/A

0DataRank · unranked

16 citations

Николай Сергеевич Карнаухов, Alexandra Mazitova, Veronika Yugai, Mark Voloshin, M.V. Tikhomirova +11 more

Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression

PLoS ONE(2021)10.1371/journal.pone.0252132

N/A

0DataRank · unranked

9 citations

Igor Bychkov, Nikolay Karnaukhov, Mark Voloshin, Rushaniya Fazliyeva, Alexander Y. Deneka +5 more